http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20020455-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-00 |
| filingDate | 2001-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff34f558fce5c8227e80609120250628 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8fb58b4f2f67dcc4d62f67ed0973d67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da331d8a3e5e909c64ab02f83c18015d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c94ee3e7d9f555b7671158b81bbdccd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdb8c9912d9c2f5ed8bdc0b3efd27c47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d794700abc659ab859dd16ab08856cf5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44e5df25a94d210bffafcde339e490f2 |
| publicationDate | 2002-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20020455-A1 |
| titleOfInvention | QUINUCLIDINE GROUPS SUBSTITUTED WITH HETEROARYL FOR THE TREATMENT OF DISEASES |
| abstract | REFERS TO QUINUCLIDINE COMPOUNDS OF FORMULA I WHERE R1 IS H, C1-C6 ALKYL, C3-C6 CYCLOALKYL, C1-C6 HALOGEN ALKYL, ARYL; R2 IS H, C1-C6 ALKYL, HALOGENATED ALKYL, CYCLOALKYL, BENZYL, ARYL; X IS O, S; W IS A GROUP a, b; V, Y ARE = N-, = CR5; ONE OF CR5 IS CH; IF U IS O, AND ES = CR5; Z ES = CR5; V IS NOT = N-; R5 IS H, ALKYL, ALKENYL, ALKINYL, CYCLOALKYL, HETEROCYCLOALKYL, OR8, OR14, NR8COR11, R7, AMONG OTHERS; R11 IS H, ALKYL, CYCLOALKYL, HETEROCYCLOALKYL, HALOGENATED ALKYL, AMONG OTHERS; R8 IS H, ALKYL, HALOGENATED ALKYL, CYCLOALKYL, HETEROCYCLOALKYL, AMONG OTHERS; R7 IS A SINGLE CYCLIC HETEROAROMATIC RING OF 5 MEMBERS, FUSION RING OF 9 MEMBERS OF FORMULA c; E IS O, S, NR3; U IS O, S, NR3; R3 IS H, ALKYL, CYCLOALKYL, HETEROCYCLOALKYL HALOGENATED; SI W IS (b); Z ES = N-, U ES NR3; R3 IS NOT PHENYL. PREFERRED COMPOUNDS ARE N - [(3R) -1-AZABICYCLO [2.2.2] OCT-3-IL] - [2,2'BTIOPHENYL-5-CARBOXAMIDE; N - [(3R) -1-AZABICYCLE FUMARATE [2.2.2] OCT-3-IL] -5- [3- (TRIFLUORomethyl) -PHENYL] -FURAN-2-CARBOXAMIDE, N 4-METHYLBENZENULPHONATE - [( 3R) -1-AZABICYCLO [2.2.2] OCT-3-IL] -5- (2-NITROPHENYL) -1,3-OXAZOL-2-CARBOXAMIDE, AMONG OTHERS. THE COMPOUNDS ARE AGONISTS OF ACETHYLCHOLINE O7 NICOTINIC NAChRO7 RECEPTORS AND MAY BE USEFUL FOR THE TREATMENT OF BULIMIA, ANOREXIA NERVOSA, WITHDRAWAL SYMPTOMS, GILLES TOURETTE SYNDROME, GLAUCOMA, SYMPTOMS ALSO ASHOLS; USING FROM 0.001mg / Kg TO 100mg / Kg |
| priorityDate | 2000-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.